Index of reports
> Cases with C-Reactive Protein Increased (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) where reactions include c-reactive protein increased. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Campath side effects in female
Reported by a physician from Germany on 2012-04-16
Patient: female, weighing 69.7 kg (153.3 pounds)
Reactions: Cardiac Failure, C-Reactive Protein Increased, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-29
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-23
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2012-01-09
End date: 2012-02-20
Other drugs received by patient: Ciprofloxacin; Cotrim Forte EU RHO; Acyclovir; Levothyroxine Sodium; Ramipril Plus
Possible Campath side effects in female
Reported by a physician from Germany on 2012-03-20
Patient: female, weighing 69.7 kg (153.3 pounds)
Reactions: C-Reactive Protein Increased, Cardiac Failure, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-29
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-23
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2012-01-09
End date: 2012-02-20
Other drugs received by patient: Levothyroxine Sodium; Acyclovir; Ramipril Plus; Cotrim Forte EU RHO; Ciprofloxacin
Possible Campath side effects in female
Reported by a physician from Germany on 2012-03-12
Patient: female, weighing 160.0 kg (352.0 pounds)
Reactions: C-Reactive Protein Increased, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-01-29
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-23
Neulasta
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2012-02-09
End date: 2012-02-20
Other drugs received by patient: Ciprofloxacin; Cotrim Forte EU RHO; Acyclovir; Ramipril Plus; Levothyroxine Sodium
Possible Campath side effects in female
Reported by a physician from Germany on 2012-03-08
Patient: female, weighing 160.0 kg (352.0 pounds)
Reactions: C-Reactive Protein Increased, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-01-29
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-01-09
End date: 2012-02-23
Neulasta
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2012-02-09
End date: 2012-02-20
Other drugs received by patient: Ciprofloxacin; Levothyroxine Sodium; Cotrim Forte EU RHO; Acyclovir; Ramipril Plus
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-21
Patient: male, weighing 69.2 kg (152.2 pounds)
Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
End date: 2011-10-07
Campath
Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-07-24
Dexamethasone
Dosage: 40 mg, qd 1-4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
Dexamethasone
Dosage: 40 mg, qd 15-18
Administration route: Oral
End date: 2011-10-03
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acetaminophen; Valaciclovir; Clemastine Fumarate
Possible Campath side effects in female
Reported by a physician from Germany on 2011-12-15
Patient: female, weighing 71.0 kg (156.2 pounds)
Reactions: C-Reactive Protein Increased, General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 unk, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-11-07
End date: 2011-11-16
Dexamethasone
Dosage: 40 unk, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-11-07
End date: 2011-11-10
Pegfilgrastim
Dosage: 6 unk, unk
Indication: Neutropenia
Start date: 2011-11-07
End date: 2011-11-07
Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acyclovir; Levofloxacin; Acetylcysteine
Possible Campath side effects in male
Reported by a physician from Germany on 2011-11-30
Patient: male, weighing 69.2 kg (152.2 pounds)
Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
End date: 2011-10-07
Campath
Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-07-24
Dexamethasone
Dosage: 40 mg, qd 1-4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
Dexamethasone
Dosage: 40 mg, qd 15-18
Administration route: Oral
End date: 2011-10-03
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Cotrim; Valaciclovir; Paracetamol
Possible Campath side effects in female
Reported by a physician from Germany on 2011-11-28
Patient: female, weighing 71.0 kg (156.2 pounds)
Reactions: C-Reactive Protein Increased, General Physical Health Deterioration, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 unk, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-11-07
End date: 2011-11-16
Dexamethasone
Dosage: 40 unk, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-11-07
End date: 2011-11-10
Pegfilgrastim
Dosage: 6 unk, unk
Indication: Neutropenia
Start date: 2011-11-07
End date: 2011-11-07
Other drugs received by patient: Levofloxacin; Acetylcysteine; Acyclovir; Cotrim; Pantoprazole Sodium
Possible Campath side effects in male
Reported by a physician from Germany on 2011-11-16
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: C-Reactive Protein Increased, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-07
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-06
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Acetaminophen; Cotrim; Valaciclovir
Possible Campath side effects in male
Reported by a physician from Germany on 2011-11-02
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: C-Reactive Protein Increased, Pneumonia Bacterial, Chills, Febrile Neutropenia, Troponin Increased, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd on days 1, 3 and 5
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-07-21
End date: 2011-08-12
Campath
Dosage: 30 mg, qd on days 1, 3 and 5
Start date: 2011-08-29
End date: 2011-09-12
Dexamethasone
Dosage: 40 mg, qdx4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-09-02
End date: 2011-09-05
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-09-02
Other drugs received by patient: Candesartan Cilexetil; Simvastatin; Nebivolol HCL; Marcumar; Pantoprazole; Novalgin; Pentacarinat; Tamsulosin HCL
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-27
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: C-Reactive Protein Increased, Pancytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, 3x/w
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-07
Dexamethasone
Dosage: 40 mg, qd
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-06-27
End date: 2011-10-06
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-06-27
End date: 2011-10-03
Other drugs received by patient: Pantoprazole Sodium; Valaciclovir; Clemastine Fumarate; Cotrim; Acetaminophen
Possible Campath side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-26
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia Bacterial, C-Reactive Protein Increased, Chills, Febrile Neutropenia, Troponin Increased, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-07-21
End date: 2011-08-12
Dexamethasone
Dosage: 40 mg, qdx4
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-09-02
End date: 2011-09-05
Narcumar
Dosage: unk
Indication: Product Used FOR Unknown Indication
Pegfilgrastim
Dosage: 6 mg, qd
Indication: Neutropenia
Start date: 2011-09-02
Other drugs received by patient: Novalgin; Pantoprazole; Tamsulosin HCL; Pentacarinat; Nebivolol HCL; Simvastin-Mepha
|